Tetracef Injection 1 gm/vial is a bactericidal beta-lactam antibiotic. It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). This disrupts the final transpeptidation step in peptidoglycan formation, an essential component of the bacterial cell wall. The resulting weakened cell wall leads to osmotic instability and bacterial cell death.
Cefepime demonstrates broad-spectrum activity against Gram-negative organisms while maintaining good efficacy against Gram-positive bacteria. Its resistance to hydrolysis by many beta-lactamases makes it effective against organisms resistant to earlier-generation cephalosporins.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Tetracef Injection 1 gm is indicated for the treatment of the following infections caused by susceptible microorganisms:
Moderate to severe pneumonia, including cases associated with bacteremia, caused by Streptococcus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Enterobacter species
Febrile neutropenia, for empiric monotherapy in selected patients
Uncomplicated and complicated urinary tract infections, including pyelonephritis
Uncomplicated skin and skin structure infections caused by methicillin-susceptible Staphylococcus aureus and Streptococcus pyogenes
Complicated intra-abdominal infections, when used in combination with metronidazole
Tetracef Injection 1 gm/vial should be administered intravenously over approximately 30 minutes or by deep intramuscular injection when appropriate.
Typical adult dosage includes:
Pneumonia: 1–2 gm IV every 12 hours
Febrile neutropenia: 2 gm IV every 8 hours
Urinary tract infections: 0.5–2 gm IV/IM every 12 hours
Skin and soft tissue infections: 2 gm IV every 12 hours
Intra-abdominal infections: 2 gm IV every 12 hours (with metronidazole)
Dosage adjustment is necessary in patients with renal impairment.
Known hypersensitivity to cefepime, cephalosporins, penicillins, or other beta-lactam antibiotics
Common adverse effects may include:
Gastrointestinal disturbances such as diarrhea or nausea
Injection site reactions
Skin rash or hypersensitivity
Serious neurological reactions such as encephalopathy, seizures, and myoclonus may occur, particularly in elderly patients or those with renal dysfunction receiving unadjusted doses.
Pregnancy Category B: Use during pregnancy only if clearly needed
Cefepime is excreted into breast milk in very low concentrations; caution is advised during breastfeeding
Dose adjustment and close monitoring are required in patients with renal impairment
Prolonged use may result in overgrowth of non-susceptible organisms
Prescribing without confirmed or strongly suspected bacterial infection increases the risk of antimicrobial resistance
Caution is advised in patients with a history of gastrointestinal disease, particularly colitis
Store below recommended temperature and protect from light
Do not use after the expiry date
Keep out of reach of children
Prescription-only medicine.
Login Or Registerto submit your questions to seller
No none asked to seller yet